Carl Valenstein is co-managing partner of Bingham’s Washington, D.C., office, as well as co-chair of the Life Sciences Group. His practice focuses on domestic and international corporate and securities matters, mergers and acquisitions, project development, and asset finance covering a wide range of industries and geographical regions. He has particular experience in the life science, telecom/electronics and cruise line industries and has worked extensively in Latin America and the Caribbean, Europe, Africa, and the Middle East.
In addition, he advises clients on international risk management, including compliance with the foreign investment review process (Exon-Florio/CFIUS), export control and sanctions, anti-money laundering, anti-boycott, and anti-corruption (FCPA) laws and regulations. He has been involved in a number of internal investigations, enforcement cases and dispute resolution proceedings relating to his transactional and regulatory practice. Carl is fluent in Spanish, Portuguese, and conversant in French and Italian.
Carl is an Adjunct Professor from Practice at the University of Michigan Law School International Transactions Clinic focusing on impact investing.